53 results
8-K/A
EX-99.1
LSTA
Lisata Therapeutics Inc
4 Oct 22
Other Events
4:42pm
.
If Cend is unable to obtain sufficient quantities of drug candidates or receive raw materials in a timely manner, Cend could be required to delay
424B3
LSTA
Lisata Therapeutics Inc
29 Jul 22
Prospectus supplement
4:06pm
, the global supply chain, with negative implications on the availability and prices of raw materials, energy prices, and its customers, as well … used over an extended period of time, and therefore relevant safety data are limited. Cell therapy companies also derive the raw materials
8-K
EX-10.1
wsm5fv5e
29 Sep 14
NeoStem Secures Debt Facility
12:00am
424B2
x1mmrbbf75 e9
30 Apr 13
Prospectus for primary offering
12:00am
424B5
5glkf2yvvro27tg1
29 Apr 13
Prospectus supplement for primary offering
12:00am